Ws Management Lllp Sarepta Therapeutics, Inc. Transaction History

Ws Management Lllp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$77.28 - $99.42 $1.21 Million - $1.56 Million	-15,706 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $645,120 - $904,361	-9,779 Reduced 38.37%	15,706 $1.45 Million
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $273,899 - $640,489	-3,791 Reduced 12.95%	25,485 $1.9 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $1.53 Million - $2.07 Million	-12,000 Reduced 29.07%	29,276 $4.11 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $1.74 Million - $3.22 Million	-18,726 Reduced 31.21%	41,276 $6.62 Million
Q4 2019 Feb 12, 2020	SELL	$76.53 - $135.58 $535,710 - $949,060	-7,000 Reduced 10.45%	60,002 $7.74 Million
Q3 2019 Nov 13, 2019	SELL	$72.81 - $156.91 $1.54 Million - $3.33 Million	-21,199 Reduced 24.03%	67,002 $5.05 Million
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $1.88 Million - $2.54 Million	-16,716 Reduced 15.93%	88,201 $13.4 Million
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $474,148 - $674,217	-4,445 Reduced 4.06%	104,917 $12.5 Million
Q4 2018 Feb 12, 2019	BUY	$97.32 - $148.76 $2.37 Million - $3.62 Million	24,362 Added 28.66%	109,362 $11.9 Million
Q2 2018 Aug 13, 2018	BUY	$71.74 - $153.69 $6.1 Million - $13.1 Million	85,000 New	85,000 $11.2 Million

560

85.5M

3.67M

1.75M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.